Stock Market Recap: Mind Medicine Inc (MNMD) Concludes at 6.06, a -1.30 Surge/Decline

Beyond market averages, investors seeking exceptional growth focus on the art of stock selection. The right picks can significantly contribute to the expansion of your wealth.

3 Tiny Stocks Primed to Explode The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.

We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.

Click here for full details and to join for free
Sponsored

After finishing at $6.14 in the prior trading day, Mind Medicine Inc (NASDAQ: MNMD) closed at $6.06, down -1.30%. In other words, the price has decreased by -$1.30 from its previous closing price. On the day, 0.59 million shares were traded. MNMD stock price reached its highest trading level at $6.18 during the session, while it also had its lowest trading level at $5.87.

Ratios:

Our goal is to gain a better understanding of MNMD by taking a closer look at its different ratios. For the most recent quarter (mrq), Quick Ratio is recorded 5.92 and its Current Ratio is at 5.92. In the meantime, Its Debt-to-Equity ratio is 0.12 whereas as Long-Term Debt/Eq ratio is at 0.12.

Upgrades & Downgrades

On July 24, 2024, ROTH MKM started tracking the stock assigning a Buy rating and target price of $36.

On May 29, 2024, Robert W. Baird started tracking the stock assigning a Outperform rating and target price of $27.Robert W. Baird initiated its Outperform rating on May 29, 2024, with a $27 target price.

Insider Transactions:

The insider trade also gives investors a glimpse into the future direction of stock prices, which can be beneficial to investors. A recent insider transaction in this stock occurred on Sep 25 ’24 when Sullivan, Mark bought 4,430 shares for $5.98 per share.

Liao Carrie sold 2,352 shares of MNMD for $14,065 on Sep 25 ’24. The Chief Accounting Officer now owns 99,543 shares after completing the transaction at $5.98 per share. On Sep 25 ’24, another insider, Barrow Robert, who serves as the Chief Executive Officer of the company, sold 19,771 shares for $5.98 each. As a result, the insider received 118,231 and left with 545,772 shares of the company.

Valuation Measures:

Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, MNMD now has a Market Capitalization of 444390080 and an Enterprise Value of 218317520.

Stock Price History:

Over the past 52 weeks, MNMD has reached a high of $12.22, while it has fallen to a 52-week low of $2.41. The 50-Day Moving Average of the stock is 1.07%, while the 200-Day Moving Average is calculated to be -15.95%.

Shares Statistics:

The stock has traded on average 795.56K shares per day over the past 3-months and 569370 shares per day over the last 10 days, according to various share statistics. A total of 41.10M shares are outstanding, with a floating share count of 27.28M. Insiders hold about 3.15% of the company’s shares, while institutions hold 144.31% stake in the company. Shares short for MNMD as of 1728950400 were 10212923 with a Short Ratio of 12.84, compared to 1726185600 on 9446090. Therefore, it implies a Short% of Shares Outstanding of 10212923 and a Short% of Float of 12.550001.

Most Popular